2014
Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicity
Langs-Barlow A, Selvaraj S, Ogbuagu O, Shabanova V, Shapiro ED, Paintsil E. Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicity. Mitochondrion 2014, 20: 71-74. PMID: 25435346, PMCID: PMC4304943, DOI: 10.1016/j.mito.2014.11.004.Peer-Reviewed Original Research
2013
Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra
Langs-Barlow A, Renner L, Katz K, Northrup V, Paintsil E. Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra. AIDS Research And Treatment 2013, 2013: 249171. PMID: 23533730, PMCID: PMC3606755, DOI: 10.1155/2013/249171.Peer-Reviewed Original ResearchMitochondrial Disease CriteriaMitochondrial toxicityNaïve childrenCharts of HIVHAART naïve childrenResource-poor settingsHAART exposureHAART initiationHIV diagnosisHIV infectionTherapy toxicityHIV managementClinical symptomsProspective studyClinical criteriaDisease criteriaHAARTYounger ageHIVMitochondrial damageSignificant differencesChildrenToxicityScoresExposure
2011
Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana
Renner L, Prin M, Li FY, Goka B, Northrup V, Paintsil E. Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana. AIDS Research And Treatment 2011, 2011: 896040. PMID: 21738861, PMCID: PMC3124224, DOI: 10.1155/2011/896040.Peer-Reviewed Original ResearchT-lymphocyte recoveryPredictors of CD4Resource-limited settingsHAART initiationKorle-Bu Teaching HospitalMost resource-limited settingsCox proportional hazards modelT-lymphocyte countsActive antiretroviral therapyMedian recovery timeProportional hazards modelPredictors of timeComplete CD4Percent CD4Antiretroviral therapyActive antiretroviralsMean ageTeaching hospitalT lymphocytesCD4Hazards modelHIVChildrenAgeSignificant predictor variables